|
Re: Possibile deals for both RVX and Zenith
|
2
|
Resverlogix Corp.
|
Oct 19, 2017 03:56PM
|
|
Re: Possibile deals for both RVX and Zenith
|
2
|
Resverlogix Corp.
|
Oct 19, 2017 04:21PM
|
|
Re: Potential
|
3
|
Zenith Epigenetics
|
Jul 21, 2021 10:41AM
|
|
Re: Potential funding for BETONMACE2 and Covid trial
|
5
|
Resverlogix Corp.
|
Oct 25, 2021 07:30PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
3
|
Resverlogix Corp.
|
Nov 14, 2022 06:20PM
|
|
Re: POTENTIAL.
|
5
|
Resverlogix Corp.
|
Nov 12, 2015 06:30PM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
4
|
Resverlogix Corp.
|
Jan 11, 2018 09:17AM
|
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 07, 2021 07:00PM
|
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 05, 2021 11:45AM
|
|
Re: Presentation
|
|
Resverlogix Corp.
|
Oct 05, 2021 07:20PM
|
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
Oct 23, 2020 11:29AM
|
|
Re: Presentation is gone
|
6
|
Resverlogix Corp.
|
May 16, 2021 01:28PM
|
|
Re: Pretty much as expected
|
4
|
Resverlogix Corp.
|
Sep 17, 2019 12:43PM
|
|
Re: Publication / Resverlogix An Author
|
3
|
Resverlogix Corp.
|
Aug 21, 2019 09:14AM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 16, 2022 07:16PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 15, 2022 07:06PM
|
|
Re: Q2 Zenith/Resverlogix Events
|
2
|
Zenith Epigenetics
|
Apr 12, 2016 05:10PM
|
|
Re: Q2 Zenith/Resverlogix Events
|
3
|
Zenith Epigenetics
|
Apr 13, 2016 08:53AM
|
|
Re: Q3 Events updated
|
2
|
Resverlogix Corp.
|
Aug 11, 2017 03:09PM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Apr 06, 2018 02:51PM
|
